MedTrace Logo

Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

NCT03132194 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 1125

Last updated 2017-05-04

No results posted yet for this study

Summary

To evaluate the therapeutic effect of DPSG and Placebo gel in the treatment of acne vulgaris.

Conditions

  • Acne Vulgaris

Interventions

DRUG

DPSG 7.5%

topical gel

DRUG

Aczone

topical gel

DRUG

Placebo

topical gel

Sponsors & Collaborators

  • Sun Pharmaceutical Industries, Inc.

    lead INDUSTRY

Principal Investigators

  • Catawba Research · http://catawbaresearch.com/contact/

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-08
Primary Completion
2017-01-16
Completion
2017-01-30

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03132194 on ClinicalTrials.gov